{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:22:50Z","timestamp":1785558170163,"version":"3.56.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1097\/bor.0000000000000034","type":"journal-article","created":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T11:47:40Z","timestamp":1391168860000},"page":"152-161","source":"Crossref","is-referenced-by-count":22,"title":["An appraisal of the 2012 American College of Rheumatology Guidelines for the Management of Gout"],"prefix":"10.1097","volume":"26","author":[{"given":"George","family":"Nuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210128","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008.","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R2-10-20210128","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","article-title":"Gout.","volume":"375","author":"Richette","year":"2010","journal-title":"Lancet"},{"issue":"Suppl 3","key":"R3-10-20210128","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/annrheumdis-2012-eular.2844","article-title":"Pain, health-related quality of life, and health status in gout in Europe.","volume":"71","author":"Langley","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R4-10-20210128","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1477-7525-10-117","article-title":"Tophi and frequent gout flares are associated with impairments to quality of life, productivity and increased healthcare resource use: results from a cross-sectional survey.","volume":"10","author":"Khanna","year":"2012","journal-title":"Health Qual Life Outcomes"},{"key":"R5-10-20210128","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/art.1780340203","article-title":"Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout.","volume":"34","author":"Pascual","year":"1991","journal-title":"Arthritis Rheum"},{"key":"R6-10-20210128","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2007.081604","article-title":"Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans.","volume":"67","author":"Singh","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R7-10-20210128","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/ar3223","article-title":"Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study.","volume":"13","author":"Pineda","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R8-10-20210128","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.rdc.2006.03.003","article-title":"Treatment of crystal arthropathy: history and advances.","volume":"32","author":"Nuki","year":"2006","journal-title":"Rheum Dis Clin North Am"},{"key":"R9-10-20210128","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","article-title":"EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R10-10-20210128","first-page":"309","article-title":"Dutch general practitioners gout guidelines.","volume":"146","author":"Roemjinders","year":"2002","journal-title":"Ned Tijd Genees"},{"key":"R12-10-20210128","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R13-10-20210128","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/rheumatology\/kem056a","article-title":"British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout.","volume":"46","author":"Jordan","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 1","key":"R14-10-20210128","first-page":"442","article-title":"Introduction of the new guideline for the management of hyperuricemia and gout with special reference to its policy in Japanese.","volume":"61","author":"Nakajima","year":"2003","journal-title":"Nippon Rinsho-Japanese J Clin Med"},{"key":"R15-10-20210128","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/annrheumdis-2013-203325","article-title":"Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative.","volume":"73","author":"Sivera","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R16-10-20210128","first-page":"2403","article-title":"Epidemiology of gout : is the incidence increasing J R","volume":"29","author":"Arromdee","year":"2002","journal-title":"heumatol"},{"key":"R17-10-20210128","first-page":"1582","article-title":"Increasing prevalence of gout and hyperuricemia over 10 years in a managed care population.","volume":"31","author":"Wallace","year":"2004","journal-title":"J Rheumatol"},{"key":"R18-10-20210128","first-page":"104","article-title":"Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study.","volume":"33","author":"Neogi","year":"2006","journal-title":"J Rheumatol"},{"key":"R19-10-20210128","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4065\/81.7.925","article-title":"Gout medication treatment patterns and adherence to standards of care from a managed care perspective.","volume":"81","author":"Sarawate","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"R20-10-20210128","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.22767","article-title":"Quality of care in the US needs improvement.","volume":"57","author":"Singh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R21-10-20210128","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/ard.2007.076232","article-title":"Gout in the UK and Germany: prevalence, comorbidities and management in General Practice 2000-2005.","volume":"67","author":"Annemans","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R22-10-20210128","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/ar2659","article-title":"Adherence with urate-lowering therapies for the treatment of gout.","volume":"11","author":"Harrold","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"R23-10-20210128","first-page":"1765","article-title":"Gout: why is this curable disease so seldom cured Ann Rheum D","volume":"71","author":"Doherty","year":"2012","journal-title":"is"},{"key":"R24-10-20210128","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology Guidelines for Management of Gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res"},{"key":"R25-10-20210128","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American College of Rheumatology Guidelines for Management of Gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis.","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res"},{"key":"R26-10-20210128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrrheum.2012.216","article-title":"New ACR gout guidelines hold some surprises.","volume":"9","author":"Bardin","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"R28-10-20210128","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1001\/jama.281.20.1900","article-title":"Are guidelines following guidelines The methodological quality of clinical practice guidelines in the peer-reviewed medical literature.","volume":"281","author":"Shaneyfelt","year":"1999","journal-title":"JAMA"},{"key":"R29-10-20210128","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in healthcare.","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"key":"R30-10-20210128","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-156-7-201204030-00009","article-title":"Guidelines international network: toward international standards for clinical practice guidelines.","volume":"156","author":"Qaseem","year":"2012","journal-title":"Ann Intern Med"},{"key":"R31-10-20210128","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.joca.2007.06.014","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis, Part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence.","volume":"15","author":"Zhang","year":"2007","journal-title":"Osteoarthritis Cartilage"},{"key":"R33-10-20210128","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jama.2009.205","article-title":"Scientific evidence underlying the ACCAHA clinical practice guidelines.","volume":"301","author":"Tricoci","year":"2009","journal-title":"JAMA"},{"key":"R34-10-20210128","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/annrheumdis-2012-201676","article-title":"Patients with gout adhere to curative treatment if informed appropriately: proof of concept observational study.","volume":"72","author":"Rees","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R37-10-20210128","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/annrheumdis-2011-200801","article-title":"Patient and provider barriers to effective management of gout in general practice: a qualitative study.","volume":"71","author":"Spencer","year":"2012","journal-title":"Ann Rheum Dis"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T18:33:03Z","timestamp":1746124383000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201403000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000034","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}